BioMarin Pharmaceutical Inc.
BMRNFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
2,854
Cost of Revenue
580
Gross Profit
2,274
Gross Margin
79.7%
Operating Income
484
Operating Margin
17.0%
Net Income
427
Net Margin
15.0%
EPS (Basic)
$2.25
EPS (Diluted)
$2.21
EBITDA
651
EBITDA Margin
22.8%
2023
12/31/2023
Revenue
2,419
Cost of Revenue
532
Gross Profit
1,887
Gross Margin
78.0%
Operating Income
186
Operating Margin
7.7%
Net Income
168
Net Margin
6.9%
EPS (Basic)
$0.89
EPS (Diluted)
$0.88
EBITDA
307
EBITDA Margin
12.7%
2022
12/31/2022
Revenue
2,096
Cost of Revenue
503
Gross Profit
1,593
Gross Margin
76.0%
Operating Income
161
Operating Margin
7.7%
Net Income
142
Net Margin
6.8%
EPS (Basic)
$0.76
EPS (Diluted)
$0.75
EBITDA
265
EBITDA Margin
12.7%
2021
12/31/2021
Revenue
1,846
Cost of Revenue
471
Gross Profit
1,376
Gross Margin
74.5%
Operating Income
-82
Operating Margin
-4.5%
Net Income
-64
Net Margin
-3.5%
EPS (Basic)
$-0.35
EPS (Diluted)
$-0.35
EBITDA
47
EBITDA Margin
2.6%
2020
12/31/2020
Revenue
1,860
Cost of Revenue
524
Gross Profit
1,336
Gross Margin
71.8%
Operating Income
-43
Operating Margin
-2.3%
Net Income
854
Net Margin
45.9%
EPS (Basic)
$4.75
EPS (Diluted)
$4.53
EBITDA
84
EBITDA Margin
4.5%